Sole2Soul for MPN

James Livermore

I'm Raising Funds for MPN Research

This summer, I'm trekking through the Rocky Mountains to raise awareness and funds for MPN research.

My Story

This is personal to me...At age 47 while visiting my mother having hip replacement 
surgery in the hospital, I had a heart attack. For years I had been a regular runner and watched my diet. That day my cholesterol was 160, HDL was 62, and my platelets were 1,030 (normal is 200-450). 

All the doctors kept saying this should not have happened to me. With one blockage not downstream but right at the aorta, if I had not already been at the hospital, I would have died. A heart attack or stroke may or may not reoccur in the future. In an instant my world lacked any certainty or predictability. Then came the news that I needed a single artery bypass to fix the physical plumbing problem. Afterwards I was referred to an oncologist. At our first meeting he informed that ''platelets had nothing to do with your heart attack." 

In 1994 it was not established that essential thrombocythemia (ET) was a separate diagnosis from polycythemia vera (PV). Regardless the only treatment to lessen the chance of platelets causing another infarction was a drug developed to treat sickle cell disease. The drug was hydroxyurea (HU), basically a low dose chemo pill but there was no cure for MPNs.

Many people cannot tolerate HU treatment. For the ones that do quite often it loses its efficacy by about six years. Most suffer from gastrointestinal issues, incredible fatigue, skin cancers, pruritus, chemo fog, night sweats, and particularly 
extreme fatigue. Inexplicably I have been taking HU for 27 plus years. I have 
been able to live my life without any restrictions. Why have I been able to do so well on HU treatment so long? Why did ET happen to me in the first place?


I'm trekking for research because... In 2005 researchers found a genetic mutation that causes my stem cells to produce excess platelets. Without treatment I would once again produce excess platelets. Research supported by the MPN Research Foundation and Canada MPNRF has led to significant developments in treating symptoms but not a cure. Supporting the research scientists is my best hope of continuing to live with ET and die of the normal vicissitudes of life. 





of your goal reached

My Supporters

  • Michael Hunstad Go James!! October 2022 $104.50
  • Anonymous Way to go James! Looking forward to hearing more about your adventure! September 2022 $250.00
  • Jon Thompson September 2022 $100.00
  • Christy Robinett Proud of your efforts to fund more research. September 2022
  • Anonymous September 2022 $1,228.00
  • Anonymous September 2022 $1,228.00
  • Meredith Livermore July 2022 $1,000.00
  • Betsy Johnson You are a testament to keep going and staying on the "sunny side" of life! Thanks for the info and the opportunity to support you and MPN research. Here's hoping for many more years . . . July 2022 $1,000.00
  • Tyler Livermore Glad to be able to support research in to MPNs so others can have as fulfilling lives with their family as you have had with us! July 2022 $1,000.00
  • James Livermore May 2022 $1,000.00

Together, We Explore MPN Research!

The landscape of MPN blood cancers is shifting, with emerging treatments and evolving perceptions that are bringing newfound hope to patients, caregivers, and clinicians. We are dedicated to supporting and uplifting the MPN blood cancer community and to investing in research initiatives globally that will lead to a better quality of life for our community. 

We’ve partnered with “Sole2Soul for MPN” - an innovative collaboration with the CURE Media Group - to empower those who are closely impacted by MPN blood cancers. We’ve created a challenging program for inner adventure while raising funds to fuel change for those who face a debilitating incurable blood cancer.  

Join us today to change the roadmap for MPN research leading to better treatments and cures

About MPN Research Foundation

The MPN Research Foundation has a single goal: to stimulate original research in pursuit of new treatments — and eventually a cure — for polycythemia vera,essential thrombocythemia and myelofibrosis, known collectively as myeloproliferative neoplasms (MPNs).